Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-240
Closed -$10K 430
2024
Q3
$10K Buy
+240
New +$9.82K ﹤0.01% 365
2023
Q2
Sell
-531
Closed -$69K 455
2023
Q1
$69K Buy
+531
New +$18.6K 0.01% 272
2021
Q4
Sell
-65
Closed -$3K 509
2021
Q3
$3K Hold
65
﹤0.01% 454
2021
Q2
$3K Sell
65
-91
-58% -$4.37K ﹤0.01% 466
2021
Q1
$7K Buy
156
+11
+8% +$499 ﹤0.01% 432
2020
Q4
$7K Hold
145
﹤0.01% 423
2020
Q3
$7K Hold
145
﹤0.01% 387
2020
Q2
$7K Sell
145
-52
-26% -$2.67K ﹤0.01% 404
2020
Q1
$9K Hold
197
﹤0.01% 388
2019
Q4
$12K Sell
197
-160
-45% -$8.9K ﹤0.01% 379
2019
Q3
$19K Buy
+357
New +$18.4K ﹤0.01% 363
2018
Q4
$53K Sell
1,116
-241
-18% -$11.9K 0.01% 278
2018
Q3
$68K Buy
+1,357
New +$68.9K 0.01% 262

Other funds holding GSK

Resources Management Corp's GSK Position: Q4 2024 in Review

Resources Management Corp sold out of GSK (GSK) in Q4 2024, closing a stake of 240 shares — an estimated $10K sold.

Resources Management Corp first reported a position in GSK in Q3 2018 and held it in 13 quarters. The position peaked at $69K in Q1 2023. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Resources Management Corp reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Resources Management Corp sold 240 GSK shares in Q4 2024, an estimated $10K.
  • Resources Management Corp first reported a position in GSK in Q3 2018 and held it in 13 quarters.
  • Resources Management Corp's GSK position peaked at $69K in Q1 2023.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Resources Management Corp's 13F filing for Q4 2024, filed 14 Feb 2025.